Loading...

RPRX

Royalty Pharma Plc Class A · NASDAQ

Performance

+2.16%

1W

-1.65%

1M

-9.03%

3M

-2.63%

6M

-0.96%

YTD

-13.99%

1Y

Profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Investment Analysis Report: RPRX

Overview

In this investment analysis report, we will delve into the financial statements of RPRX, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...

See more ...

Technical Analysis of RPRX 2024-05-31

Overview:

In analyzing the technical indicators for RPRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates